Amneal makes new executive appointments

BRIDGEWATER, N.J. — Generic drug maker Amneal Pharmaceuticals has added four new executives, the company said.

Joseph Todisco has been appointed SVP global corporate strategy and business development. Previously serving as VP business development for Ranbaxy, Todisco will be responsible for the growth of Amneal's U.S. generics business and development of partnerships, mergers and acquisitions.

Narasimhan Mani has been appointed director of global business development and portfolio, and will head the identification and execution of international opportunities and alliances, research and development product management and selection, and corporate portfolio management. Before working for Amneal, Mani was business development manager for Johnson & Johnson.

Pranav Mehta has been appointed global director of purchasing, overseeing research and development procurement, commercial active pharmaceutical ingredients and packaging. Mehta previously worked for JPMorgan Chase & Co.

Hanumantha Rao has been appointed director of business development and will seek alliances in Europe, Asia, Africa and the Middle East. Before working for Amneal, Rao was assistant director of strategic sourcing and business development for North America and Europe at Dr. Reddy's Labs.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.